|
| ID |
DDInter801 |
| Drug Type |
small molecule |
| Molecular Formula |
C6H12O6 |
| Molecular Weight |
180.156
|
| Description |
Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer, Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. There are even proposals for its use in accelerating senescence in mice, rats, and Drosophila, for its association with ovarian cancer, or even for the potential treatment of focal segmental glomerulosclerosis. Nevertheless, none of these ongoing studies have yet provided formal elucidation for their proposals.
As a naturally occurring sugar, it may be found in a number dairy products. Even then, however, it is not generally used as a sweetener considering it is only about 30% as sweet as sucrose. Regardless, although it is predominantly used as a pathway to generate glucose fuel for the human body, galactose is involved as an ingredient in some commonly used vaccines and non-prescription products.
|
| ATC Classification |
V08DA02
V04CE01
|
| IUPAC Name |
(2R,3S,4S,5R)-2,3,4,5,6-Pentahydroxyhexanal |
| InChI |
Inchi=1S/C6H12O6/C7-1-3(9)5(11)6(12)4(10)2-8/H1,3-6,8-12H,2H2/T3-,4+,5+,6-/M0/S1 |
| InChI Key |
GZCGUPFRVQAUEE-KCDKBNATSA-N |
| Canonical SMILES |
[H]C(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO |
| Useful Links |
DrugBank
PubChem
|